TI
BLFS icon

Trexquant Investment’s BioLife Solutions BLFS Stock Holding History

Trexquant Investment’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,272
Closed -$310K – 1454
2023
Q1 		$310K Buy
+14,272
New +$321K 0.01% 1185
2022
Q2 		– Sell
-27,951
Closed -$635K – 1533
2022
Q1 		$635K Buy
+27,951
New +$736K 0.03% 657

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Trexquant Investment's BLFS Position: Q2 2023 in Review

Trexquant Investment sold out of BioLife Solutions (BLFS) in Q2 2023, closing a stake of 14,272 shares — an estimated $310K sold.

Trexquant Investment first reported a position in BLFS in Q1 2022 and held it in 2 quarters. The position peaked at $635K in Q1 2022. 156 funds tracked by Wall St. Rank hold BLFS as of Q2 2023.

  • Trexquant Investment reported no remaining BioLife Solutions position as of Q2 2023 after selling out during the quarter.
  • Trexquant Investment sold 14,272 BioLife Solutions shares in Q2 2023, an estimated $310K.
  • Trexquant Investment first reported a position in BioLife Solutions in Q1 2022 and held it in 2 quarters.
  • Trexquant Investment's BioLife Solutions position peaked at $635K in Q1 2022.
  • 156 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2023.

Based on Trexquant Investment's 13F filing for Q2 2023, filed 11 Aug 2023.